The positive and negative concordance rates between the Epi-TOP Pancreatic assay and the tumor markers CA 19-9 and CEA were determined to be 72.73%, 77.78%, and 89.47%, 85.71%, respectively. This evidence concerns the gene CEACAM5 and neoplasm.